SPRO
SPRO
NASDAQ · Biotechnology

Spero Therapeutics Inc

$1.26
-0.01 (-0.79%)
As of Aug 15, 2:14 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,387.3% upside
Low Target $21.51
Average Target $31.34
High Target $48.77
Current Price $1.26
Current
$1.26
Target
$31.34
$21.51 $31.34 avg $48.77
Scenario Analysis
Bear Case
$21.51
1,607.1%
Low target
Base Case
$31.34
+2,387.3%
Avg target
Bull Case
$48.77
+3,770.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.08
-59.1% from high
52-Week Low
$1.08
+16.7% from low
Target vs 52W High
$31.34
+917.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%